Example: marketing
HIGHLIGHTS OF PRESCRIBING INFORMATION …
Feraheme is an iron replacement product indicated for the treatment of iron ... therapies are readily available for the treatment of hypersensitivity reactions [see Adverse Reactions (6.1)]. ... renal, or cardiac function, and of concomitant disease or other drug therapy
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
ESPEN Guidelines on Enteral Nutrition: Adult Renal Failure
espen.infoassociated with renal failure and with the under-lying disease process and its associated complica-tions, but also the derangements in nutrient balances due to renal replacement therapies (RRTs). This is especially true when higher effi-ciency depurative techniques are used (continuous therapies such as continuous veno-venous haemo-
ESPEN Guidelines on Parenteral Nutrition: Adult Renal Failure
espen.infoRenal replacement therapies have profound effects on metabolism and nutrient balances. C 2 Poor nutritional status is a major risk factor for morbidity and mortality, thus determining outcomes. B 3 (continued on next page)
Clinical Practice Guideline Haemodialysis - Renal
ukkidney.orgare aware of the interactions between renal replacement therapies and pregnancy which may impact on family planning and modality decisions. [1D] For dialysis patients wishing to continue their pregnancy, we recommend changing as early as possible to an individualised, augmented haemodialysis schedule.
Intravenous Iron Replacement Therapy (Feraheme, Injectafer ...
www.uhcprovider.comIntravenous Iron Replacement Therapy ... two of the following intravenous iron therapies each (Note: Laboratory values should be obtained within 1 to 3 ... Without End Stage Renal Disease (ESRD) Feraheme and Injectafer are medically necessary when the following criteria are met: For initial therapy, all of the following: o Diagnosis of IDA and ...
COMMUNITY HOSPITAL CARE
www.moh.gov.sgoccupational therapies) after the acute hospitals’ management and treatment for conditions such as stroke, joint replacement surgeries, fractures, and other types of surgeries. The community hospitals also . 4 ... Patients with renal conditions who are
Osteoarthritis: Diagnosis and Treatment
www.aafp.orgJan 01, 2012 · therapies. All patients with osteoarthritis ... Discuss total joint replacement for osteoarthritis of the hip, knee, or shoulder if steps below are unsuccessful ...
SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eureplacement, if indicated, continuation of pembrolizumab may be considered after corticosteroid taper, if needed. Otherwise treatment should be discontinued. Hypothyroidism Hypothyroidism may be managed with replacement therapy without treatment interruption. Hepatitis NOTE: for RCC patients treated with pembrolizumab in combination with ...